These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2885776)

  • 21. A multicentre study of vigabatrin for drug-resistant epilepsy.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; Miketta RM; Sherry KM; Szabo GK
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):95S-100S. PubMed ID: 2667606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.
    Loiseau P; Hardenberg JP; Pestre M; Guyot M; Schechter PJ; Tell GP
    Epilepsia; 1986; 27(2):115-20. PubMed ID: 3514204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study.
    Luna D; Dulac O; Pajot N; Beaumont D
    Epilepsia; 1989; 30(4):430-7. PubMed ID: 2502384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gamma-vinyl-GABA on the human electroencephalogram.
    Hammond EJ; Wilder BJ
    Neuropharmacology; 1985 Oct; 24(10):975-84. PubMed ID: 2999635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans.
    Ben-Menachem E
    Epilepsia; 1989; 30 Suppl 3():S12-4. PubMed ID: 2767013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients.
    Liegeois-Chauvel C; Marquis P; Gisselbrecht D; Pantieri R; Beaumont D; Chauvel P
    Epilepsia; 1989; 30 Suppl 3():S23-5. PubMed ID: 2767016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
    Ben-Menachem E; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):79S-85S. PubMed ID: 2474312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy.
    Malmgren K; Hedström A; Granqvist R; Malmgren H; Ben-Menachem E
    Epilepsy Res; 1996 Nov; 25(3):199-207. PubMed ID: 8956917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vigabatrin as an anticonvulsant against pentylenetetrazol seizures.
    Sayin U; Cengiz S; Altug T
    Pharmacol Res; 1993 Dec; 28(4):325-31. PubMed ID: 8140032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind dose reduction study of vigabatrin in complex partial epilepsy.
    Sivenius MR; Ylinen A; Murros K; Matilainen R; Riekkinen P
    Epilepsia; 1987; 28(6):688-92. PubMed ID: 3319536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
    Neal MJ; Shah MA
    Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Sarlund H; Riekkinen P
    Neurology; 1988 May; 38(5):743-7. PubMed ID: 3362372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coadministration of vigabatrin and valproate in children with refractory epilepsy.
    Armijo JA; Arteaga R; Valdizán EM; Herranz JL
    Clin Neuropharmacol; 1992 Dec; 15(6):459-69. PubMed ID: 1477847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin).
    Gram L; Sabers A; Dulac O
    Epilepsia; 1992; 33 Suppl 5():S26-9. PubMed ID: 1425497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA in epilepsy: the pharmacologic basis.
    Gale K
    Epilepsia; 1989; 30 Suppl 3():S1-11. PubMed ID: 2548836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of vigabatrin on the electroencephalogram in rats.
    Halonen T; Pitkänen A; Koivisto E; Partanen J; Riekkinen PJ
    Epilepsia; 1992; 33(1):122-7. PubMed ID: 1733745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy.
    Reynolds EH
    Epilepsia; 1992; 33 Suppl 5():S30-4; discussion S34-5. PubMed ID: 1425498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.